I don't have much respect for the brokerage house Harleys but in a research report released Friday they rate Novogen a buy.
They have a valuation over $4 for the stock and cited positive developments in its drugs pipeline keys to the buy rating.
Cure for Cancer, here we come.
Novogen rated a buy by Hartleys
Add KZA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
41.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $29.58M | |||
| Open | High | Low | Value | Volume |
| 41.0¢ | 44.0¢ | 39.5¢ | $100.6K | 244.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2720 | 39.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 41.0¢ | 7317 | 1 |
View Market Depth
| Last trade - 16.10pm 15/11/2019 (20 minute delay) ? |
 (live)
|
|||||
|
Last
41.0¢ |
Change
0.000 ( 1.36 %) |
||||
| Open | High | Low | Volume | ||
| 41.0¢ | 42.0¢ | 40.0¢ | 59404 | ||
| Last updated 15.58pm 15/11/2019 (live) ? | |||||
| KZA (ASX) Chart |